7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(5-methyl-8-oxa-2,5-diazaspiro[3.5]nonan-2-yl)phthalazin-1-amine;N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine

C144H180F3N29O2 — CID 158860735

IUPAC7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(5-methyl-8-oxa-2,5-diazaspiro[3.5]nonan-2-yl)phthalazin-1-amine;N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine
SMILESCc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CC(C)(N(C)C)C4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CC(C)(N(C)C)C4)cc23)c1F.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CC(N(C)C)C4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CC(N(C)C)C4)cc23)c1F.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CC5(COCCN5C)C4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CCOCC4)cc23)c1F
InChIInChI=1S/C26H33N5O.C25H33N5.C24H30FN5.C24H31N5.C23H28FN5.C22H25FN4O/c1-17-7-6-8-22(18(17)2)19(3)27-25-24-13-21(9-10-23(24)20(4)28-29-25)31-14-26(15-31)16-32-12-11-30(26)5;1-16-9-8-10-21(17(16)2)18(3)26-24-23-13-20(11-12-22(23)19(4)27-28-24)30-14-25(5,15-30)29(6)7;1-15-8-7-9-20(22(15)25)16(2)26-23-21-12-18(10-11-19(21)17(3)27-28-23)30-13-24(4,14-30)29(5)6;1-15-8-7-9-21(16(15)2)17(3)25-24-23-12-19(29-13-20(14-29)28(5)6)10-11-22(23)18(4)26-27-24;1-14-7-6-8-20(22(14)24)15(2)25-23-21-11-17(29-12-18(13-29)28(4)5)9-10-19(21)16(3)26-27-23;1-14-5-4-6-19(21(14)23)15(2)24-22-20-13-17(27-9-11-28-12-10-27)7-8-18(20)16(3)25-26-22/h6-10,13,19H,11-12,14-16H2,1-5H3,(H,27,29);8-13,18H,14-15H2,1-7H3,(H,26,28);7-12,16H,13-14H2,1-6H3,(H,26,28);7-12,17,20H,13-14H2,1-6H3,(H,25,27);6-11,15,18H,12-13H2,1-5H3,(H,25,27);4-8,13,15H,9-12H2,1-3H3,(H,24,26)/t19-;18-;16-;17-;2*15-/m111111/s1
InChIKeyJAPSZQXFGIYXMT-OXEIYPCGSA-N
MW2406.22 g/mol
LogP27.00
Rot. Bonds28

About 7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(5-methyl-8-oxa-2,5-diazaspiro[3.5]nonan-2-yl)phthalazin-1-amine;N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine

7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(5-methyl-8-oxa-2,5-diazaspiro[3.5]nonan-2-yl)phthalazin-1-amine;N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine (PubChem CID 158860735) has the molecular formula C144H180F3N29O2 and a molecular weight of 2406.22 g/mol. Its IUPAC name is 7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(5-methyl-8-oxa-2,5-diazaspiro[3.5]nonan-2-yl)phthalazin-1-amine;N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine.

Molecular Properties

Compound Name7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(5-methyl-8-oxa-2,5-diazaspiro[3.5]nonan-2-yl)phthalazin-1-amine;N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine
PubChem CID158860735
Molecular FormulaC144H180F3N29O2
Molecular Weight2406.22 g/mol
Exact Mass2404.48
IUPAC Name7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(5-methyl-8-oxa-2,5-diazaspiro[3.5]nonan-2-yl)phthalazin-1-amine;N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine
SMILESCc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CC(C)(N(C)C)C4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CC(C)(N(C)C)C4)cc23)c1F.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CC(N(C)C)C4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CC(N(C)C)C4)cc23)c1F.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CC5(COCCN5C)C4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CCOCC4)cc23)c1F
InChIInChI=1S/C26H33N5O.C25H33N5.C24H30FN5.C24H31N5.C23H28FN5.C22H25FN4O/c1-17-7-6-8-22(18(17)2)19(3)27-25-24-13-21(9-10-23(24)20(4)28-29-25)31-14-26(15-31)16-32-12-11-30(26)5;1-16-9-8-10-21(17(16)2)18(3)26-24-23-13-20(11-12-22(23)19(4)27-28-24)30-14-25(5,15-30)29(6)7;1-15-8-7-9-20(22(15)25)16(2)26-23-21-12-18(10-11-19(21)17(3)27-28-23)30-13-24(4,14-30)29(5)6;1-15-8-7-9-21(16(15)2)17(3)25-24-23-12-19(29-13-20(14-29)28(5)6)10-11-22(23)18(4)26-27-24;1-14-7-6-8-20(22(14)24)15(2)25-23-21-11-17(29-12-18(13-29)28(4)5)9-10-19(21)16(3)26-27-23;1-14-5-4-6-19(21(14)23)15(2)24-22-20-13-17(27-9-11-28-12-10-27)7-8-18(20)16(3)25-26-22/h6-10,13,19H,11-12,14-16H2,1-5H3,(H,27,29);8-13,18H,14-15H2,1-7H3,(H,26,28);7-12,16H,13-14H2,1-6H3,(H,26,28);7-12,17,20H,13-14H2,1-6H3,(H,25,27);6-11,15,18H,12-13H2,1-5H3,(H,25,27);4-8,13,15H,9-12H2,1-3H3,(H,24,26)/t19-;18-;16-;17-;2*15-/m111111/s1
InChIKeyJAPSZQXFGIYXMT-OXEIYPCGSA-N
XLogP27.00
TPSA280.96 Ų
H-Bond Donors6
H-Bond Acceptors31
Rotatable Bonds28
Heavy Atoms178
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002406.22
LogP ≤ 527.00
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1031

Analyze 7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(5-methyl-8-oxa-2,5-diazaspiro[3.5]nonan-2-yl)phthalazin-1-amine;N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(5-methyl-8-oxa-2,5-diazaspiro[3.5]nonan-2-yl)phthalazin-1-amine;N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine?
The IUPAC name of 7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(5-methyl-8-oxa-2,5-diazaspiro[3.5]nonan-2-yl)phthalazin-1-amine;N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine (CID 158860735) is 7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(5-methyl-8-oxa-2,5-diazaspiro[3.5]nonan-2-yl)phthalazin-1-amine;N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine.
What is the SMILES notation for 7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(5-methyl-8-oxa-2,5-diazaspiro[3.5]nonan-2-yl)phthalazin-1-amine;N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine?
The canonical SMILES for 7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(5-methyl-8-oxa-2,5-diazaspiro[3.5]nonan-2-yl)phthalazin-1-amine;N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine is Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CC(C)(N(C)C)C4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CC(C)(N(C)C)C4)cc23)c1F.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CC(N(C)C)C4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CC(N(C)C)C4)cc23)c1F.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CC5(COCCN5C)C4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(N4CCOCC4)cc23)c1F.
What is the InChIKey of 7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(5-methyl-8-oxa-2,5-diazaspiro[3.5]nonan-2-yl)phthalazin-1-amine;N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine?
The InChIKey is JAPSZQXFGIYXMT-OXEIYPCGSA-N. The full InChI is InChI=1S/C26H33N5O.C25H33N5.C24H30FN5.C24H31N5.C23H28FN5.C22H25FN4O/c1-17-7-6-8-22(18(17)2)19(3)27-25-24-13-21(9-10-23(24)20(4)28-29-25)31-14-26(15-31)16-32-12-11-30(26)5;1-16-9-8-10-21(17(16)2)18(3)26-24-23-13-20(11-12-22(23)19(4)27-28-24)30-14-25(5,15-30)29(6)7;1-15-8-7-9-20(22(15)25)16(2)26-23-21-12-18(10-11-19(21)17(3)27-28-23)30-13-24(4,14-30)29(5)6;1-15-8-7-9-21(16(15)2)17(3)25-24-23-12-19(29-13-20(14-29)28(5)6)10-11-22(23)18(4)26-27-24;1-14-7-6-8-20(22(14)24)15(2)25-23-21-11-17(29-12-18(13-29)28(4)5)9-10-19(21)16(3)26-27-23;1-14-5-4-6-19(21(14)23)15(2)24-22-20-13-17(27-9-11-28-12-10-27)7-8-18(20)16(3)25-26-22/h6-10,13,19H,11-12,14-16H2,1-5H3,(H,27,29);8-13,18H,14-15H2,1-7H3,(H,26,28);7-12,16H,13-14H2,1-6H3,(H,26,28);7-12,17,20H,13-14H2,1-6H3,(H,25,27);6-11,15,18H,12-13H2,1-5H3,(H,25,27);4-8,13,15H,9-12H2,1-3H3,(H,24,26)/t19-;18-;16-;17-;2*15-/m111111/s1.
What are the key properties of 7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(5-methyl-8-oxa-2,5-diazaspiro[3.5]nonan-2-yl)phthalazin-1-amine;N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine?
7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(5-methyl-8-oxa-2,5-diazaspiro[3.5]nonan-2-yl)phthalazin-1-amine;N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine has a molecular weight of 2406.22 g/mol, XLogP of 27.00, 28 rotatable bonds, 6 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for 7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)azetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methylphthalazin-1-amine;7-[3-(dimethylamino)-3-methylazetidin-1-yl]-N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methylphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-(5-methyl-8-oxa-2,5-diazaspiro[3.5]nonan-2-yl)phthalazin-1-amine;N-[(1R)-1-(2-fluoro-3-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylphthalazin-1-amine is sourced from PubChem (CID 158860735), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).